MiR-155 regulates immune modulatory properties of mesenchymal stem cells by targeting TAK1-binding protein 2

Journal of Biological Chemistry

Volumn 288, Issue 16, 2013, Pages 11074-11079

  Xu, Chunliang ^a   Ren, Guangwen ^a   Cao, Gang ^a   Chen, Qing ^a   Shou, Peishun ^a   Zheng, Chunxing ^a   Du, Liming ^a   Han, Xiaoyan ^a   Jiang, Menghui ^a   Yang, Qian ^a   Lin, Liangyu ^a   Wang, Guan ^a   Yu, Pengfei ^a   Zhang, Xin ^a   Cao, Wei ^a   Brewer, Gary ^a,c   Wang, Ying ^a   Shi, Yufang ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEINS; MESENCHYMAL STEM CELL; MOLECULAR MECHANISM; REGULATORY PROPERTIES;

FLOWCHARTING;

CELL CULTURE;

BINDING PROTEIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MICRORNA 155; TAK1 BINDING PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOMODULATION; IMMUNOREGULATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-1BETA; MESENCHYMAL STROMAL CELLS; MICE; MICRORNAS; NITRIC OXIDE SYNTHASE TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876584007     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.414862     Document Type: Article

References (25)

1. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., and Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
2. Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A., Low, W. C., Largaespada, D. A., and Verfaillie, C. M. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49.
3. Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Deans, R. J., Krause, D. S., and Keating, A. (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7, 393-395.
4. Caplan, A. I. (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 213, 341-347.
5. Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., and Ringdén, O. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441.
6. Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C., and Shi, Y. (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2, 141-150.
7. Shi, Y., Hu, G., Su, J., Li, W., Chen, Q., Shou, P., Xu, C., Chen, X., Huang, Y., Zhu, Z., Huang, X., Han, X., Xie, N., and Ren, G. (2010) Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 20, 510-518.
8. Shi, Y., Su, J., Roberts, A. I., Shou, P., Rabson, A. B., and Ren, G. (2012)How mesenchymal stem cells interact with tissue immune responses. Trends Immunol. 33, 136-143.
9. Ren, G., Zhao, X., Zhang, L., Zhang, J., L'Huillier, A., Ling, W., Roberts, A. I., Le, A. D., Shi, S., Shao, C., and Shi, Y. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J. Immunol. 184, 2321-2328.
10. Xu, G., Zhang, L., Ren, G., Yuan, Z., Zhang, Y., Zhao, R. C., and Shi, Y. (2007) Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res. 17, 240-248.
11. O'Connell, R. M., Rao, D. S., Chaudhuri, A. A., and Baltimore, D. (2010) Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10, 111-122.
12. Baltimore, D., Boldin, M. P., O'Connell, R. M., Rao, D. S., and Taganov, K. D. (2008) MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9, 839-845.
13. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., and Baltimore, D. (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U.S.A. 104, 1604-1609.
14. Ceppi, M., Pereira, P. M., Dunand-Sauthier, I., Barras, E., Reith, W., Santos, M. A., and Pierre, P. (2009) MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 106, 2735-2740.
15. O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., and Baltimore, D. (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. U.S.A. 106, 7113-7118.
16. Eskildsen, T., Taipaleenmäki, H., Stenvang, J., Abdallah, B. M., Ditzel, N., Nossent, A. Y., Bak, M., Kauppinen, S., and Kassem, M. (2011) MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 108, 6139-6144.
17. Kanayama, A., Seth, R. B., Sun, L., Ea, C. K., Hong, M., Shaito, A., Chiu, Y. H., Deng, L., and Chen, Z. J. (2004) TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535-548.
18. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P., and Burge, C. B. (2003) Prediction of mammalian microRNA targets. Cell 115, 787-798.
19. Zhou, H., Huang, X., Cui, H., Luo, X., Tang, Y., Chen, S., Wu, L., and Shen, N. (2010) miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 116, 5885-5894.
20. Ren, G., Su, J., Zhang, L., Zhao, X., Ling, W., L'huillie, A., Zhang, J., Lu, Y., Roberts, A. I., Ji, W., Zhang, H., Rabson, A. B., and Shi, Y. (2009) Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27, 1954-1962.
21. Parekkadan, B., and Milwid, J. M. (2010) Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 12, 87-117.
22. Singer, N. G., and Caplan, A. I. (2011) Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. 6, 457-478.
23. Huang, J., Zhao, L., Xing, L., and Chen, D. (2010) MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 28, 357-364.
24. Lakshmipathy, U., and Hart, R. P. (2008) Concise review: MicroRNA expression in multipotent mesenchymal stromal cells. Stem Cells 26, 356-363.
25. Kim, Y. J., Hwang, S. J., Bae, Y. C., and Jung, J. S. (2009) MiR-21 regulates adipogenic differentiation through the modulation of TGF-β signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 27, 3093-3102.